| Honey and Nigella sativa against COVID‐19 in Pakistan (HNS‐COVID‐PK): A multicenter placebo‐controlled randomized clinical trial S Ashraf, S Ashraf, M Ashraf, MA Imran, L Kalsoom, UN Siddiqui, I Farooq, ... Phytotherapy Research 37 (2), 627-644, 2023 | 88 | 2023 |
| Zoonotic and reverse zoonotic events of SARS-CoV-2 and their impact on global health K Munir, S Ashraf, I Munir, H Khalid, MA Muneer, N Mukhtar, S Amin, ... Emerging microbes & infections 9 (1), 2222-2235, 2020 | 74 | 2020 |
| Knowledge, attitude, and practice of clinicians about antimicrobial stewardship and resistance among hospitals of Pakistan: a multicenter cross-sectional study S Ashraf, S Ashraf, M Ashraf, MA Imran, ZA Choudhary, HT Hafsa, ... Environmental Science and Pollution Research, 1-11, 2022 | 18 | 2022 |
| COVID-19: A potential trigger for thyroid dysfunction S Ashraf, MA Imran, S Ashraf, H Hafsa, S Khalid, MK Akram, M Ghufran, ... The American journal of the medical sciences 362 (3), 303-307, 2021 | 14 | 2021 |
| Efficacy of honey and Nigella sativa against COVID-19: HNS-COVID-PK Trial S Ashraf, S Ashraf, MA Imran, M Ashraf, L Kalsoom, UN Siddiqui, ... medRxiv, 2020 | 12 | 2020 |
| Prophylactic potential of honey and Nigella sativa L. against hospital and community-based SARS-CoV-2 spread: a structured summary of a study protocol for a … S Ashraf, S Ashraf, R Akmal, M Ashraf, L Kalsoom, A Maqsood, MA Imran, ... Trials 22, 1-3, 2021 | 11 | 2021 |
| A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK … S Ashraf, S Ashraf, M Ashraf, MA Imran, L Kalsoom, UN Siddiqui, I Farooq, ... Trials 22, 1-3, 2021 | 6 | 2021 |
| Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial S Ashraf, S Ashraf, M Ashraf, I Farooq, R Akmal, MA Imran, L Kalsoom, ... Trials 23 (1), 58, 2022 | 3 | 2022 |
| Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised … S Ashraf, S Ashraf, I Farooq, S Ashraf, M Ashraf, MA Imran, L Kalsoom, ... Trials 22, 1-3, 2021 | 3 | 2021 |
| ROLE OF ALPRAZOLAM AS A HEART RATE LOWERING AGENT IN ANXIOUS PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME (A-ACS-PK TRIAL) S Ashraf, R Akmal, A Mustaqeem, M Ashraf, I Farooq, MA Imran, S Ashraf, ... Journal of the American College of Cardiology 81 (8_Supplement), 1204-1204, 2023 | | 2023 |
